热门资讯> 正文
Travere上调4.75亿美元可转换优先票据价格，为2029年可转换票据再融资
2026-05-07 13:05
- Travere Therapeutics (TVTX) on Wednesday announced the pricing of its underwritten offering of $475M aggregate principal amount of 0.50% convertible senior notes due 2032.
- The sale of the notes is expected to close on May 11. The aggregate principal amount of the offering was increased from the previously announced offering size of $400M.
- Travere also granted the underwriters of the notes a 30-day option to purchase up to an additional $50M aggregate principal amount of notes, solely to cover over-allotments.
- The company's shares were down 1.9% in extended trading.
More on Travere Therapeutics
- Travere Therapeutics, Inc. (TVTX) Q1 2026 Earnings Call Transcript
- Travere Therapeutics: Still Undervalued Post FSGS Approval
- Travere Therapeutics: Re-Rating Potential As Filspari Wins Full Approval
- Travere Therapeutics plans $400M convertible notes offering
- Travere Therapeutics Non-GAAP EPS of $0.05 beats by $0.10, revenue of $124.5M misses by $12.27M
推荐文章
AI算力革命下半场，黄仁勋大笔押注光纤！港美股光通信主线行情爆发，哪些重点标的值得关注？
美股机会日报 | 特朗普傍晚抵达北京，黄仁勋“压哨入场”！英伟达盘前涨超2%； 科技FOMO主导！存储、半导体重启升势，美光涨超5%
英特尔、高通、AMD股价今日为何下跌？
传统工业股成AI热潮受益者 走势与芯片板块近乎同步
一图看懂 | 营收、经调整净利双双超预期！京东Q1总收入3157亿元，同比增近5%；外卖业务亏损环比大幅收窄
新股申购 | 拓璞数控冲击港股“商业航天第一股”！驭势科技一手入场费3045.40港元
期权交易指南 | 存储、CPU迎“史诗级”暴涨！如何利用期权锁定利润？阿里绩后或现7%大波动
一周IPO | 4月“零破发”！5月更嗨？天星医疗首战暴涨118%；机器人扎堆！乐动机器人暗盘大涨近90%，翼菲科技火热招股中
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
